Host-Directed Therapeutics

May 20, 2025 0

Due: June 6, 2025 The JPEO-CBRND is interested in late-stage development of host-directed therapeutics or repurposing of United States Food and Drug Administration (FDA) licensed therapeutics that are threat-agnostic with the potential for activity across Read More

Reimagining Available Vaccines and Envisioning Novelty

May 20, 2025 0

Due: June 13, 2025 The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA) supports the warfighter through medical countermeasure development for biological threats, both known and unknown. Preventative treatments and Read More

1 2 3 4 58